• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    More On ABPI

    Accentia Biopharmaceuticals, Inc. (ABPI)

    -Other OTC
    0.00 0.00(0.00%) Mar 30, 10:44AM EDT
    |Pre-Market : NaN
    Add to Portfolio
    Prev Close:0.00
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:0.55
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.00 - 0.03
    Volume:0
    Avg Vol (3m):112,210
    Market Cap:N/A
    P/E (ttm):N/A
    EPS (ttm):-0.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for ABPI at this time.

    Comparison

    Symbol% ChgMkt Cap
    ABPI 0.00%N/A
    AGENUp 5.52%365.12M
    BIIBUp 0.41%101.26B
    IMMUUp 4.85%363.28M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-08) :N/A
    Quarterly EPS Est (Jun-08) :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Accentia Biopharmaceuticals, Inc., a biotechnology company, primarily discovers, develops, and commercializes immunotherapies to treat autoimmune related diseases and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback